J. McKillop

Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy.

A. Bielawska, Y. Hannun, Joseph Cheng, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Oxidative stress sensitizes bladder cancer cells to TRAIL mediated apoptosis by down-regulating anti-apoptotic proteins.

P. Lu, L. Kasman, J. McKillop, 2009, The Journal of urology.

Acute rapamycin treatment augments both protein ubiquitination and Akt activation in pressure‐overloaded rat myocardium

M. Zile, C. Baicu, D. Kuppuswamy, 2011, American journal of physiology. Heart and circulatory physiology.

mTOR complex 2 mediates Akt phosphorylation that requires PKCε in adult cardiac muscle cells.

D. Kuppuswamy, S. Balasubramanian, Dorea L. Pleasant, 2013, Cellular signalling.

FasL gene therapy: a new therapeutic modality for head and neck cancer

T. Day, A. El-Zawahry, J. Norris, 2006, Cancer Gene Therapy.

Generation and initial characterization of conditionally immortalized chromaffin cells

M. Eaton, J. Sagen, T. Lopez, 2000, Journal of cellular biochemistry.

Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction

M. Oudega, P. Cejas, M. Eaton, 2000, Pain.

Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts

A. El-Zawahry, J. McKillop, C. Voelkel-Johnson, 2005, BMC Cancer.

Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report

A. Bielawska, Y. Hannun, L. Obeid, 2006, Cancer Gene Therapy.

Oxidative stress sensitizes bladder cancer cells to TRAIL mediated apoptosis by down-regulating anti-apoptotic proteins.

P. Lu, L. Kasman, J. McKillop, 2009, The Journal of urology.